We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

35 hedge funds and large institutions have $60.8M invested in LYRA THERAPEUTICS INC in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $55.9M → $60.8M (+$4.96M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.05% less ownership

Funds ownership: 1.07%1.03% (-0.05%)

20% less funds holding

Funds holding: 4435 (-9)

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
35
Holders Change
-9
Holders Change %
-20.45%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
15
Closed
12
Calls
Puts
Net Calls
Net Calls Change

LYRA Hedge Fund Activity: Q3 2021 in Review

35 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2021, worth a combined $60.8M — up 8.9% from $55.9M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of LYRA and 3 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 7 added.

The largest buyer was Parian Global Management, opening a new position worth an estimated $917K. The largest seller was Ikarian Capital, cutting an estimated $1.67M.

  • 35 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2021, down from 44 in Q2 2021.
  • Funds reported $60.8M of LYRA THERAPEUTICS INC stock for Q3 2021, up 8.9% quarter-over-quarter.
  • 3 funds opened new LYRA THERAPEUTICS INC positions in Q3 2021 and 12 closed out, a net change of -9 holders.
  • The largest LYRA THERAPEUTICS INC buyer in Q3 2021 was Parian Global Management, an estimated $917K added.
  • The largest LYRA THERAPEUTICS INC seller in Q3 2021 was Ikarian Capital, an estimated $1.67M sold.

Based on aggregated 13F filings for Q3 2021.